Literature DB >> 20688557

The Yin and Yang of bone morphogenetic proteins in cancer.

Ashok Singh1, Rebecca J Morris.   

Abstract

Bone morphogenetic proteins (BMPs) were first studied as growth factors or morphogens of the transforming growth factor-beta superfamily. These growth molecules, originally associated with bone and cartilage development, are now known to play an important role in morphogenesis and homeostasis in many other tissues. More recently, significant contributions from BMPs, their receptors, and interacting molecules have been linked to carcinogenesis and tumor progression. On the other hand, BMPs can sometimes function as a tumor suppressor. Our report highlights these new roles in the pathogenesis of cancer that may suggest novel targets for therapeutic intervention.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688557      PMCID: PMC2939311          DOI: 10.1016/j.cytogfr.2010.06.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  150 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells.

Authors:  Haiyun Deng; Ryouji Makizumi; T S Ravikumar; Huali Dong; Wancai Yang; Weng-Lang Yang
Journal:  Exp Cell Res       Date:  2007-01-10       Impact factor: 3.905

3.  Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.

Authors:  Emma-Leena Alarmo; Jenita Rauta; Päivikki Kauraniemi; Ritva Karhu; Tuula Kuukasjärvi; Anne Kallioniemi
Journal:  Genes Chromosomes Cancer       Date:  2006-04       Impact factor: 5.006

4.  Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2.

Authors:  S F Arnold; E Tims; B E Mcgrath
Journal:  Cytokine       Date:  1999-12       Impact factor: 3.861

5.  Cloning of human bone morphogenetic protein type IB receptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs.

Authors:  H Ide; M Katoh; H Sasaki; T Yoshida; K Aoki; Y Nawa; Y Osada; T Sugimura; M Terada
Journal:  Oncogene       Date:  1997-03-20       Impact factor: 9.867

6.  Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.

Authors:  Johanna M Ketolainen; Emma-Leena Alarmo; Vilppu J Tuominen; Anne Kallioniemi
Journal:  Breast Cancer Res Treat       Date:  2010-02-25       Impact factor: 4.872

7.  Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4.

Authors:  S Piccolo; Y Sasai; B Lu; E M De Robertis
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

8.  The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients.

Authors:  Magdalena Bieniasz; Katarzyna Oszajca; Mak Eusebio; Jacek Kordiak; Jacek Bartkowiak; Janusz Szemraj
Journal:  Lung Cancer       Date:  2009-03-25       Impact factor: 5.705

9.  BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells.

Authors:  S Buckley; W Shi; B Driscoll; A Ferrario; K Anderson; D Warburton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-09-05       Impact factor: 5.464

10.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

Authors:  P ten Dijke; H Yamashita; T K Sampath; A H Reddi; M Estevez; D L Riddle; H Ichijo; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  33 in total

1.  Construction of a eukaryotic expression vector pEGFP-C1-BMP-2 and its effect on cell migration.

Authors:  Xiao-ying Wang; Zhong-hua Chen; Ru-yi Zhang; Sen-quan Liu; Zhu Mei; Ying-ying Yu; Xiong Zhang; Qiang Xia; Yue-min Ding
Journal:  J Zhejiang Univ Sci B       Date:  2012-05       Impact factor: 3.066

Review 2.  Keratinocyte stem cells and the targets for nonmelanoma skin cancer.

Authors:  Ashok Singh; Heuijoon Park; Thaned Kangsamaksin; Anupama Singh; Nyssa Readio; Rebecca J Morris
Journal:  Photochem Photobiol       Date:  2012-01-31       Impact factor: 3.421

3.  Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study.

Authors:  Xia Pu; Yuanqing Ye; Margaret R Spitz; Liang Wang; Jian Gu; Scott M Lippman; Michelle A T Hildebrandt; Waun Ki Hong; John D Minna; Jack A Roth; Ping Yang; Xifeng Wu
Journal:  Clin Cancer Res       Date:  2012-09-13       Impact factor: 12.531

4.  Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.

Authors:  Reema S Wahdan-Alaswad; Kara L Bane; Kyung Song; Dorjee T N Shola; Jorge A Garcia; David Danielpour
Journal:  Mol Cancer Res       Date:  2012-03-27       Impact factor: 5.852

Review 5.  BMPs and their clinical potentials.

Authors:  Meejung Kim; Senyon Choe
Journal:  BMB Rep       Date:  2011-10       Impact factor: 4.778

6.  Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.

Authors:  George S Karagiannis; Ann Treacy; David Messenger; Andrea Grin; Richard Kirsch; Robert H Riddell; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2014-04-19       Impact factor: 6.603

7.  BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization.

Authors:  Cynthia L Forsman; Brandon C Ng; Rachel K Heinze; Claire Kuo; Consolato Sergi; Rajaram Gopalakrishnan; Douglas Yee; Daniel Graf; Kathryn L Schwertfeger; Anna Petryk
Journal:  Dev Biol       Date:  2012-10-24       Impact factor: 3.582

8.  Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.

Authors:  Laura D Hover; Christian D Young; Neil E Bhola; Andrew J Wilson; Dineo Khabele; Charles C Hong; Harold L Moses; Philip Owens
Journal:  Cancer Lett       Date:  2015-07-30       Impact factor: 8.679

9.  Inhibitory effect of bone morphogenetic protein-2 on the proliferation of giant cell tumor of bone stromal cells in vitro.

Authors:  Baohua He; Guanping He; Xiaofei Zheng; Lihua Li; Mei Li; Hong Xia
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

Review 10.  Bone morphogenetic protein signaling in musculoskeletal cancer.

Authors:  Myrto Bami; Andreas F Mavrogenis; Andrea Angelini; Mandy Milonaki; Evanthia Mitsiokapa; Dimitrios Stamoulis; Panayotis N Soucacos
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-04       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.